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Perspective

Telemedicine for Pediatric Nephrology: Perspectives on
COVID-19, Future Practices, and Work Flow Changes
Rupesh Raina, Nikhil Nair, Aditya Sharma, Ronith Chakraborty, and Sarah Rush, Delphi Panelists
Although the use of telemedicine in rural areas has increased steadily over the years, its use was rapidly Complete author and article
implemented during the onset of the coronavirus disease 2019 (COVID-19) crisis. Due to this rapid information provided before
implementation, there is a lack of standardized work ﬂows to assess and treat for various nephrotic references.
conditions, symptoms, treatment modalities, and transition processes in the pediatric population. To Kidney Med. 3(3):412-425.
provide a foundation/suggestion for future standardized work ﬂows, the authors of this report have Published online March 28,
developed standardized work ﬂows using the Delphi method. These work ﬂows were informed based on 2021.
results from cross-sectional surveys directed to patients and providers. Most patients and providers were doi: 10.1016/
satisﬁed, 87% and 71%, respectively, with their telemedicine visits. Common issues that were raised with j.xkme.2021.01.007
the use of telemedicine included difﬁculty procuring physical laboratory results and a lack of personal
warmth during telemedicine visits. The work ﬂows created based on these suggestions will both enhance
safety in treating patients and allow for the best possible care.
© 2021 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

INTRODUCTION
The swift rise of telemedicine in the age of coronavirus
disease 2019 (COVID-19) has had large implications for
the current and future practice of medicine. Although the
growth of telemedicine has been slow during the past few
years, the sudden onset of the COVID-19 pandemic has led
to the rapid growth of telemedicine. Not only can telemedicine be used as a direct virtual contact between the
physician and patient, known as the televisit, but it can also
be used to triage patients with midlevel provider virtual
visits through the use of “telesupervision.”1 Because much
of the care delivered by pediatric nephrology is based on
laboratory results, many of the in-person visits can be
conducted through telemedicine.
Although the physical examination, an important part
of each visit, cannot be done with telemedicine, recent
studies have shown that the use of telemedicine is associated with positive outcomes, as outlined in Table 1.2-8
However, deciding when a patient is an appropriate
candidate for a telemedicine visit and how to evaluate and
treat through telemedicine have not yet been standardized
in pediatric nephrology. Therefore, we discuss the benefits
and drawbacks of telemedicine, as well as perspectives on
the standardization of work flows for common pediatric
nephrology pathologies.
METHODS
The literature search, article review, data extraction, and
results were completed by the authors, who submitted
their results to the work group for discussion. All individuals were responsible for reviewing and proposing
recommendations for the telemedicine work flows. Disagreements between members were resolved by
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quantifying votes using the RAND Corporation/University
of California Los Angeles appropriateness method and
subsequently calculating a disagreement index.9,10
The modified Delphi method was used to establish the
strength of each recommendation. Delphi method panelists were selected based on their skills and previously
displayed expertise in different areas of pediatric
nephrology. The Delphi method is an iterative method of
determining consensus toward clinical problems. An initial
list of problems was identified and multiple rounds of
voting and discussion took place both over email and
through online meetings until agreements were reached.
The panel did not grade the evidence but instead used it as
part of a suggested guideline because in pediatric literature, there are very limited randomized controlled trials to
support the strength of gradation. The PubMed/MEDLINE,
EMBASE, and Cochrane databases were searched to identify
publications relevant to telemedicine and nephrology in
the pediatric population.
For the survey, we characterized telemedicine experiences by patients and providers in a cross-sectional
fashion. The physician survey was created by a team of
pediatric nephrologists and intensivists from the Delphi
panel. The survey was pilot tested with 10 pediatric nephrologists at Akron Children’s Hospital. Pediatric nephrologists were approached electronically through the
pedneph and the pcrrt list servers. The physician survey had 17
questions with both open-ended and closed-ended responses on a Likert scale. The survey collected information
related to the experiences of telemedicine by both patients
and providers and was gathered between February 28,
2020, and June 30, 2020.
Patients’ responses on telemedicine clinical services
were collected in the United States. This assessment was
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Table 1. RCTs of Telemedicine Services for Patients With Kidney Failure and Earlier Stages of CKD
Care
Supplemented by
Telemedicine
Supporting HHD
therapies

Study
Berman
et al3 (2013)

Design
RCT
parallel

Intervention
Remote
monitoring +
standard HHD
care

Provider
None

Chow and
Wong4
(2010)

RCT
parallel

Telephone call +
standard care

None

Hospital to home
transition of care

Dey et al6
(2016)

Cohort
(pre/post)

Remote
monitoring +
standard HHD
care

Health
care team

Supporting home
PD therapy

Gallar et al2
(2007)

RCT
parallel

Videoconference

Health
care team

Supporting home
PD therapy

Hayashi
et al7 (2017)

RCT
parallel

Health
care team

Jahromi
et al8 (2016)

RCT
parallel

Platform
(telemetry) for
selfmanagement
and remote
monitoring
Telephone call +
standard care

Li et al5
(2014)

RCT
parallel

Telephone call +
standard care

Outcomes
Clinical:
hospitalization, ED
visits, Karnofsky
score
Patient-reported
measures: QoL
(SF-36)
Patient-reported
measures: QoL
(KDQOL-SF)

Sample
Size
43

85

Patient-reported
measures: QoL
(KDQOL-36),
patient satisfaction
w/satisfaction
(QUEST)
Clinical:
hospitalization

22

Supporting selfmanagement and
in between HD
care

Patient-reported
measures: QoL
(KDQOL-SF)

18

None

Mental health

Patient-reported
measures: DASS

60

None

Hospital to home
transition care

Clinical:
hospitalization
readmission

135

57

Results
Signiﬁcant
improvement
in
hospitalization
and ED visits
Signiﬁcant
improvement
in patient
satisfaction
and social
functioning
domain
No signiﬁcant
improvement
in outcomes

Signiﬁcant
improvement
in
hospitalization
rate
Signiﬁcant
improvement
in patientreported QoL
factors
Signiﬁcant
improvement
in DASS
scores
Signiﬁcant
improvement
in QoL factors

Abbreviations: CKD, chronic kidney disease; DASS, Depression Anxiety and Stress Scale; ED, emergency department; HD, hemodialysis; HHD, home hemodialysis;
KDQOL-SF, Kidney Disease Quality of Life–Short Form, PD, peritoneal dialysis; QoL, quality of life; QUEST, Quebec User Evaluation of Satisfaction With Assistive
Technology; RCT, randomized controlled trial; SF-36, 36-Item Short Form Health Survey.

sporadic and not center based, with data available from
various surveys that were either hospital or institution
based, including satisfaction surveys from Healthgrades
and Hospital Consumer Assessment of Healthcare Providers and Systems. The patient questionnaire was
collected from March 30, 2020, to June 30, 2020. These
reports were anonymous, voluntary, and not compensated.
Patients were given the survey by the authors of this
article, along with help from providers who were
approached to fill out the physician questionnaire. Consent
to publish the deidentified findings was obtained with the
completion of the survey through an informed statement
at the beginning and conclusion of the survey, gathering
the consent of the parent/guardian in situations in which it
was necessary.
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FROM BEDSIDE TO WEBSITE: THE CHANGE IN
PARADIGM OF THE PATIENT VISIT
Pediatric nephrology consultations are largely based on
laboratory assessment, with patient interaction centered
around disease education and explanation of treatment
choices. Thus, much of what transpires in an in-person
interaction can be translated to a video interaction.2 Even
before the onset of the COVID-19 pandemic, it had been
shown that the use of telemedicine is associated with
decreased rates of hospital admissions, greater patient
follow-up, and increased patient satisfaction when
compared with the traditional in-person visit. In a randomized controlled trial, Gallar et al2 showed a significantly lower rate of hospitalization among patients using
telemedicine compared with traditional in-person services.
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Furthermore, Reddy and Aronoff11 reported a 44%
reduction in missed appointments when using telemedicine services versus in-person consultations. As such,
telemedicine has proved to be a developing alternative to
in-person visits. In the field of pediatric nephrology, the
traditional in-person visit often includes establishing patient rapport, meeting with families, and discussing laboratory results and prognosis, much of which can be
completed through the use of telemedicine, with the
exception of the physical examination.
During a telemedicine visit, providers need to learn to
remain “present.” If the provider and patient are together
in a room and the provider happens to look away or
move a short distance away, the patient will generally
still have a sense that the provider is present.12 However,
when the clinician can only be seen on the monitor and
he or she looks away, the patient may feel like the provider is no longer present. To avoid this, it is particularly
important to be sure to review the patient’s chart before
the televisit instead of doing so while on screen. One
way to maintain a presence is to have proper eye contact.
Providers can practice looking at the camera instead of at
the image of the patient on the screen so that the patient
feels that the clinician is “looking them in the eyes.”
Conveying emotional support over a screen is harder to
achieve than in person.13 Simply sitting quietly for a
minute or two can be helpful after delivery difficult
information.
With technology making great leaps and bounds,
accessibility to patients through the virtual world has
become a bourgeoning reality. The development of multiple video-capable applications and technologies has made
communication better than ever before. In response to the
COVID-19 pandemic, nephrologists at Mt. Sinai have used
all technologies that allow for video communication,
including Facetime, Zoom, and WhatsApp.14 We recommend the use of these services because they are free to
patients and easily accessible to use. In our survey, most
providers used Zoom or EPIC to conduct their telemedicine
visits.
PERSPECTIVES OF PROVIDERS AND
PATIENTS DURING THE COVID-19 PANDEMIC
To examine the experiences with telemedicine of both
pediatric nephrologists and patients, we conducted a survey with 197 pediatric nephrologists and 400 pediatric
nephrology patients from February 28, 2020, to June 30,
2020. The results showed a positive response among both
pediatric nephrologists and patients alike. Most physicians
expressed satisfaction with the capabilities of telemedicine
visits, with only 10% expressing dissatisfaction with the
clinical aspect of telemedicine and 4% expressing disappointment with telemedicine overall. In addition, patients
reported their experiences with telemedicine to be as good as
if not better than the traditional in-person visit (Table 215).
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LACK OF STANDARDIZATION WITH
TELEMEDICINE: BILLING AND WORK FLOWS
One of the primary limitations posed by telemedicine is the
relative lack of billing coverage from Medicare and private
insurance companies throughout the United States. Previously, only 20% of states required payment parity between
in-person visits and televisits. However, with the rise of
COVID-19, Medicare began providing broader billing
coverage, which will extend through the end of the
pandemic, allowing for greater use of telemedicine services.
Furthermore, with the 1135 waiver, Medicare allows for
billing coverage for televisits for patients who have been
established with their physician along with new patients.
In addition, the Centers for Medicare & Medicaid
Services (CMS) has established codes that should be used
for telemedicine visits through electronic charting services, telephone calls, and digital media consulting
(Table 316). Although this has greatly broadened the
coverage and use of telemedicine, the conclusion of the
pandemic may signify a step back with respect to telemedicine if coverage is not continuously present. It is
imperative to have standardization of such coverage by
Medicare and private insurance companies alike to further
evolve the care of pediatric nephrology and other patients
alike. The recent Physician Fee Schedule Final Rule from
CMS, effective January 1, 2021, finalized the establishment of coding and payment schedules for virtual visits
on an interim final basis. This has greatly broadened the
coverage of telehealth and creates a strong precedent for
private insurance companies to follow. Although payment schedules from CMS do not typically apply to the
treatment of pediatric patients, private insurance companies that cover pediatric patients often follow the lead
of Medicare. Following the conclusion of the pandemic,
it is imperative that payment schedules, under the lead of
CMS, adapt with the evolution of medical care to advance
the treatment of pediatric nephrology and other patients
alike.
SUGGESTED WORK FLOWS FOR
TELEMEDICINE USE IN THE FUTURE FOR
PEDIATRIC NEPHROLOGY
Although telemedicine has been used for many years, a
more widespread adoption of these services has occurred
as a result of the COVID-19 pandemic. Given the diverse
nature of hospital systems and insurance coverage, finding
a standardized method of applying telemedicine will pose
a challenge in the near term. As both provider and patient
comfort with virtual care increase, delivery will continue
to become more refined and established as a routine
component of health care practice. Inclusion of metrics
around the quality of telemedicine encounters will also be
critical. We have developed generalized suggestions and
work flows through the Delphi method that can serve as
the foundation for standardized telemedicine work flows.
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Table 2. Telemedicine Experience as Reported by Patients and Pediatric Nephrologists
Experience
Perceived beneﬁts:
disease speciﬁc
Perceived beneﬁts:
contextual speciﬁc

Perceived beneﬁts:
consultation
speciﬁc
User satisfaction

User dissatisfaction
Challenges

Cost

Suggestions for
improvement

Patients
90% of patients were comfortable
communicating about their health with their
provider by telemedicine
>90% of patients were able to save time
traveling to the hospital/clinic for appointments
(n = 400); most patients reported that virtual
visits were better in terms of travel time to clinic
(85%), ﬁnding convenient time for their visit
(71%), and amount of time waiting for the
clinician (53%)
>90% thought that their provider was able to
understand their health condition, received
adequate attention, and the care provided via
telemedicine was consistent with the in-person
visits (n = 400)
Patient satisfaction (n = 400) with quality of the
telemedicine experience was similarly positive
to their in-person visits (87%); a subset of
patients (n = 250) provided scores in the
Healthgrades system, and their satisfaction
level was similar during the COVID-19
pandemic (mean score, 4.2-4.6 of 5) with
telemedicine visits in comparison to 2019
ratings (mean, 4.2-4.8 of 5)15; in the
Healthgrades ratings, patients had
overwhelmingly positive reviews of their
telemedicine visits: 67% gave score of 9-10 of
10; 24%, 7-8; only 9%, <6
Patients (n = 400) reported that the ability to
have a physical examination (80%) and overall
quality of visit (60%) was better with ofﬁce visits
Patients (n = 400) reported that personal
connection with clinician was better with inperson setting in 60% of cases; not
comfortable sharing conﬁdential information in
30% of cases; patients (n = 400) reported
inability to show clinician a physical problem
80% of times; the cost of the visit was better for
the in-person clinic visits 33% of time

65% of patients were deﬁnitely willing to co-pay
$10-$25; 28% were deﬁnitely willing to pay
$26-$50; and 18% were deﬁnitely willing to pay
full cost of televisit
Changes in cost to patient to make it more
affordable?

Pediatric Nephrologists

Physicians (n = 321) reported 25% better, 42%
similar, and 33% worse telemedicine visit
attendance compared with in-person visits by
patients

Physicians reported being very satisﬁed/
satisﬁed (14%/57%) or neutral (25%)

(n = 13) 4% were dissatisﬁed with telemedicine
overall
Physicians (n = 321) reported technologyrelated challenges (36%) followed by inability to
perform physical examinations (30%) or
laboratory tests (18%), unfamiliarity with
telemedicine (9%), and being uninformed about
billing (7%); the 321 responders stated that
telemedicine services were not connected to
the electronic health record in 60% of cases,
had no waiting room feature to queue in
patients in 32% of cases, and had restrictions in
performing telemedicine services in 24% of
cases
Inability to use billing codes for telemedicine in
9% of cases
Physicians (n = 321) suggested that better
equipment (39%) followed by pre-check of
patients (25%) and increased training (25%)
would improve the experience; w12% did not
suggest changes

Abbreviation: COVID-19, coronavirus disease 2019.

We believe that the implementation plans we present can
serve as guides to assist with standardization of work flows
in the future practice of pediatric nephrology.
COVID-19 and the Dialysis Unit
COVID-19 has significantly changed the dynamics of
hospitals around the world. Particularly in settings that
require high levels of patient contact, such as in dialysis
units, it is of utmost importance to enact preventative
measures. Dialysis units can prepare for COVID-19 using
Kidney Med Vol 3 | Iss 3 | May–June 2021

the Centers for Disease Control and Prevention’s (CDC’s)
COVID-19 Outpatient Dialysis Facility Preparedness
Assessment Tool.17 The CDC recommends implementing
processes to appropriately and routinely screen patients for
any symptoms or potential exposures to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Once screened, facilities should ideally place patients 6
feet apart, with medically stable patients having the option
of waiting in their vehicles to prevent further contact.
Transportation to and from the isolation rooms must
415
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Table 3. Suggested Billing Codes for Telemedicine Use Based on Advice of American Medical Association
Telehealth Billing/Documentation Requirements Updated 5/4/2020
Performed
SARS-CoV-2–Focused
Type of Visit/
by
ICD-10-CM Codes
Treatment
In-ofﬁce E/M visit
Physician/
Asymptomatic: Z11.59 No
QHP
exposure to SARS-CoV-2:
03.818 Contact with SARSCoV-2, suspected exposure:
Z20.828

CPT Codes

Place of Service

New: 99201-99205 Established:
99212-99215 Consult: 9924199245

11 physician
ofﬁce; 19 off
campus outpatient
hospital; 20 urgent
care facility; 22 on
campus outpatient
hospital
NA

Asymptomatic: Z11.59; no
exposure to SARS-CoV-2:
Z03.818; Contact with
SARS-CoV-2, suspected
exposure: Z20.828
Asymptomatic: Z11.59; no
exposure to SARS-CoV-2:
Z03.818; contact with
SARS-CoV-2, suspected
exposure: Z20.828

Swab collection included in E/M:
99000

Physician/
QHP

Asymptomatic: Z11.59; no
exposure to SARS-CoV-2:
Z03.818; contact with
SARS-CoV-2, suspected
exposure: Z20.828

Patient evaluated
for SARS-CoV-2
testing need:
online

Physician/
QHP

Patient setup and
education on
Telehealth services
Remote
physiologic
monitoring
treatment (ﬁrst 20
min)
Remote
physiologic
monitoring
treatment (each
additional 20 min)
Collection and
interpretation of
physiologic data
digitally stored
and/or transmitted
by patient
Telehealth visit
emergency
department

Physician/
QHP/
clinical staff
Physician/
QHP

Asymptomatic: Z11.59; no
exposure to SARS-CoV-2:
Z03.818; contact with
SARS-CoV-2, suspected
exposure: Z20.828
NA

New patient: 99201 (typical time
10 min). 99202 (typical time 20
min), 99203 (typical time 30 min),
99204 (typical time 45 min),
99205 (typical time 60 min)
Current patient: 99212 (typical
time 10 min), 99213 (typical time
15 min), 99214 (typical time 25
min), 99215 (typical time 40 min)
New or established patient: 99421
(5-10 min), 99422 (11-20 min),
99423 (≥21 min); payor guidelines
may vary; G2010 Remote image:
G2012 virtual check-in
99453: remote monitoring of
physiologic parameter(s)

Patient swab
sample collection

Clinical staff

SARS-CoV-2 test
performed

Est Mychart
Telehealth/
Mychart
telehealth

Patient evaluated
for SARS-CoV-2
testing need by E/
M telehealth

87635

19 off campus
outpatient
hospital; 22 on
campus outpatient
hospital; 81
independent
laboratory
11 physician
ofﬁce; 19 off
campus outpatient
hospital; 20 urgent
care facility; 22 on
campus outpatient
hospital
11 physician ofﬁce

11 physician ofﬁce

NA

99457: remote physiologic
monitoring treatment management,
ﬁrst 20 min

11 physician ofﬁce

Physician/
QHP

NA

99458: remote physiologic
monitoring treatment management,
each additional 20 min

11 physician ofﬁce

Physician/
QHP

NA

99091: collection and
interpretation of physiologic data

11 physician ofﬁce

99281 (self-limited or minor);
99282 (low to moderate severity);
99283 (moderate severity); 99284
(high severity, no immediate
signiﬁcant threat to life or
physiologic function); 99285 (high
severity, immediate signiﬁcant
threat to life or physiologic
function)

23 physician ofﬁce

Physician/
QHP

Abbreviations: CPT, Current Procedural Terminology; E/M, evaluation and management; ICD-10-CM, International Classiﬁcation of Diseases, Tenth Revision, Clinical
Modiﬁcation; N/A, not available; QHP, qualiﬁed health plan; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Information adapted from Special Coding Advice During COVID-19 Public Health Emergency. American Medical Association; May 4, 2020.16
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follow strict procedures. This step will ensure that they can
be treated in an effective manner with minimal exposure
risk to other patients. Patients who are persons under
investigation or have confirmed SARS-CoV-2 infection
should ideally be dialyzed in separate closed-off rooms.
Ideally, 3 separate rooms for SARS-CoV-2–positive patients, persons under investigation, and patients who show
no symptoms but have had contact with persons with
confirmed SARS-CoV-2 infection should be created.
However, if a separate room is not available, SARS-CoV2–positive patients and persons under investigation should
be treated away from traffic flow, such as at an end-of-row
station.17 Adherence to universal source control measures
is crucial to prevent spread among dialysis units and
should thus be followed by patients and staff alike. Health
care providers on the dialysis shift must not be changed or
swapped to prevent cross-contamination. All caregivers
should have increased personal protective equipment
when treating patients in isolation or defer dialysis and
testing to a hospital for testing/treatment (Fig 1).
Acute Nephrotic Syndrome Work Flow
In regard to an emergent in-patient condition such as acute
nephrotic syndrome, it is important to establish clear lines
of communication between the specialist and the local

health care team. Daily video visits should take place that
include regular blood pressure charting and observation
for fever, rash, joint pain, and heart disease along with
absence of serologic evidence of streptococcal infection. If
the patient shows improvement, daily video consults can
be reduced in frequency and transferred back to the primary pediatrician for follow-up. Advanced practitioners,
nephrology nurses, dieticians, nephrology social workers,
and providers should communicate with each other on the
progress of their patient to ensure that all parties are aware
of updates. If the patient shows a rapidly progressing
condition, edema, or accelerated hypertension, the patient
needs to visit the emergency department and be admitted
immediately (Fig 2).
Glomerular Disease Management
There are 4 key components when managing glomerular
diseases: immunosuppression, monitoring and diagnosis,
supportive care, and in-person visits. Immunosuppression
use needs to be carefully managed. In the case of
confirmed or suspected infection, it is important to cease
all medication to avoid an exacerbation of infection.18
Even without a suspected infection, it is important to
consider switching to short reversible agents. This can
allow for easy cessation of medication in case of infection.

Hemodialysis Patient Categories During COVID-19
COVID-19-positive patients
Persons who have tested positive for COVID-19 virus and are clinically stable
to treat in a dialysis center and/or clinically stable COVID-19-positive patients
recently discharged from the hospital setting
Isolations shift within a dialysis clinic

Persons Under Investigation (PUI) with History and
Symptoms of COVID-19
This includes persons who have been tested for COVID-19 and are awaiting test
results and persons who have not yet been tested for COVID-19
Treatment in a dialysis center must be cohorted into isolation shifts
dedicated to PUIs

Asymptomatic Persons Reporting Close-Contact
Exposure to COVID-19
This includes persons who have been tested for COVID-19 and are awaiting test
results and persons who have not yet been tested for COVID-19
Treatment in a dialysis center must be cohorted into isolation shifts
dedicated to PUIs

Dialysis Shift and Personnel
Avoid having health care staff change dialysis shifts to avoid cross-contamination
and infection; dialyze in place with rigorous use of personal protective equipment
(PPE) and isolation; defer dialysis and refer a patient to a hospital for testing
and/or treatment

Figure 1. Hemodialysis during coronavirus disease 2019 (COVID-19) work ﬂow.

Kidney Med Vol 3 | Iss 3 | May–June 2021
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Figure 2. Nephrotic syndrome work ﬂow.

Until the end of the COVID-19 pandemic, providers
should avoid immunosuppressive therapy for patients who
are otherwise stable to avoid any undue risk. However, in
the case of clinical trials, the potential benefits need to be
considered, especially regarding promising therapies.
Medication should be given as an oral or subcutaneous
agent at home or in an isolated section of the treatment
center.18
For diagnosis and monitoring, laboratory tests should
be done outside of a hospital to limit risk if possible.
Biopsies should be restricted to cases for which it is
absolutely necessary. This limits the time that patients
have to spend in hospitals and reduces their risk for
infection. Supportive care measures do not need to be
altered, with angiotensin-converting enzyme inhibitors
and angiotensin II receptor blockers appropriate for use
based on current evidence. For stable patients, all visits
should be conducted electronically. Patients with suspected infection should conduct an initial telemedicine
visit to assess symptoms and triage further treatment13
(Fig 3).
Chronic Kidney Disease Work Flow
The first step for any patient with chronic kidney disease
is to determine their clinical status and the extent to
which treatments can be conducted virtually. Virtual
visits are more feasible with early-stage chronic kidney
disease, whereas in stages 4 or 5, in-person visits may be
necessary to submit and conduct laboratory tests. The
health care team, composed of provider, advanced
practitioners, nurses, dieticians, and/or social workers,
should work together to meet with both the parent and
patient to establish a regular schedule and train the
family on how to use a given telemedicine service. When
all parties are comfortable with the telemedicine system,
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a review of the clinical status and laboratory test results
should be presented to the patient and his or her family,
with adolescent children given the opportunity to discuss
their condition with physicians privately. Before
concluding the meeting, the health care team should
review recommendations for any lifestyle or medication
changes. Patients and their families should also be
educated on the importance of home blood pressure
monitoring for early detection of clinical status. Future
visits should also be determined in accordance with the
patient’s current conditions and the risk for their condition worsening (Fig 4).
Urinary Tract Infection Algorithm
Physicians should conduct a telemedicine visit with patients for urinary tract infections if they have unexplained
fever, vomiting, or dysuria. If the patient is younger than 2
years and has persistent vomiting and a sick appearance
after the initial visit, he or she should be referred to the
emergency department. Even if none of those emergent
symptoms are present, urine cultures should be collected.
If vesicoureteral reflux, severe lower tract symptoms, or a
high fever with leukocyturia is present, empirical oral
antibiotics should be prescribed. If these symptoms are not
present, symptomatic treatment should be prescribed. In
both instances, a follow-up visit should be scheduled
within 2 days with repeat urine cultures taken. If there is
no growth in the urine culture, antibiotic treatment may
be halted. If significant growths are seen, antibiotic therapy
should be continued for another 48 hours. Additionally,
the antibiotic treatment should be carried out for 10 to 14
days with a kidney ultrasound during a follow-up visit 2
weeks later if a response is noted. If there is no response,
urine cultures should be repeated and antibiotics should be
changed (Fig 5).
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Figure 3. Glomerular disease management. Abbreviations: ACE, angiotensin-converting enzyme; ANCA, antineutrophil cytoplasmic
antibodies; ARB, angiotensin II receptor blocker; CDC, Centers for Disease Control and Prevention; COVID-19, coronavirus disease
2019; eGFR, estimated glomerular ﬁltration rate; PCV13, pneumococcal conjugate vaccine; PPSV23, pneumococcal polysaccharide vaccine; RPGN, rapidly progressive glomerulonephritis; TMP-SMX, trimethoprim-sulfamethoxazole.

Pediatric Transplant Telemedicine Protocol
Although the risk for acquiring SARS-CoV-2 infection from
organ donation is low, all organ donors are required to be
screened.18 However, the capability to conduct screenings
varies according to the transplantation center. Any donor
or donated organ testing positive for SARS-CoV-2 cannot
be used for transplantation (Fig 6). Patients are asked to
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not travel to high-risk areas for at least 2 weeks before their
donations.18 Contact tracing and a detailed history for
donors are imperative, especially if traveled recently. In
nonemergent situations, these donors are asked to prolong
their donation by 14 to 28 days.18
Regardless of where patients are living, those who have
undergone transplantation are presumed to be at a higher
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Chronic Kidney Disease Protocol

1

2

3

Establish telemedicine platform for
video conference
AND
Healthcare team has been trained

Patient’s clinical status is
deemed appropriate for
telemedicinevisit

Scheduling of visit carried out by
healthcare team member and
patient or parent

Visit is conducted with a review of
clinical status/labs by each discipline,

4 video assessment of pertinent physical

7

(Optional)
A portion of the visit for the
adolescent patient is conducted
independently of the parents

8

Visit concluded with review of
recommendations using teach back
principles and plans are made for
future telemedicine or in-personvisits

ﬁnding & feedback from patient/parent

(Optional)
Team members (eg, physician, nurse,

5 dietician, social worker, etc) meet online
prior to admitting patient/parent to visit

6

Training of patient/parent by
healthcare team member to
enable TM visit conducted prior
to the scheduled visit

Figure 4. Chronic kidney disease work ﬂow. Abbreviation: TM, telemedicine.

risk for SARS-CoV-2 infection, along with other severe
diseases. Risk-benefit analysis should be done to determine
whether transplantation can be postponed to a later date.18
Decisions should be made on a case-by-case basis, and
concerns should be shared among the transplant team and
patient after carefully assessing the risks and benefits. All
members of the transplant team should assess each patient
and consider using new pandemic-specific consent forms
to communicate the increased risk of the procedure.
Before and after a transplantation procedure, telemedicine should be conducted when clinically possible. Routine
laboratory tests should be deferred and if required, strict
appointments should be kept to minimize the risk for the
patient being exposed to SARS-CoV-2. Any decisions to
treat rejection with augmented immunosuppression need
to incorporate the risk for SARS-CoV-2 infection and
should be tailored to each individual patient.
Care of pediatric transplant recipients with SARS-CoV-2
infection must be individualized, but the use of telemedicine enhances the ability of providers to more frequently
monitor patient symptoms and status. For immunosuppressed pediatric transplant recipients who contract SARSCoV-2 infection, telemedicine may allow those without
significant illness to avoid hospitalization. Stable pediatric
transplant recipients may benefit from substitution of a
telemedicine visit rather than an in-person visit for routine
care if both their provider and the parent/patient believes
this is reasonable.
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Transition From the Pediatric to the Adult World
Given the pandemic, the process of transitioning patients
from pediatric to adult care can be disrupted and affect
the patient’s ability to conduct disease self-management.
Our suggested protocol for transition is derived from
the RISE (recognition, insight, self-reliance, and establish) protocol from Akron Children’s Hospital, which
is based on previously stated survey findings and literature review (Fig 7).19 (p. 51) This protocol specifies 4
main competency areas for patients to achieve before
transition:
1. Recognition of their disease process, reason for transplant,
and the healthcare system;
2. Insight into the short- and long-term impact of their disease, therapy, non-adherence, and emotional needs;
3. Self-reliance in scheduling and attending appointments,
refilling medications, and identifying urgent/emergent
changes to their health on their own;
4. Establish healthy lifestyle choices, life-long adherence to
medications and follow-up, psychosocial skills, and educational/vocational goals.19

These 4 competency areas are key to an effective transition. Helping patients develop self-reliance and establish
healthy choices will improve their autonomy, reduce the
emotional burden of their disease and treatment, and
minimize disruptions to their daily life. The focus of the
recognition and insight goals is to educate the patient about
all aspects of their disease. Transition is a process that begins
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Figure 5. Urinary tract infection (UTI) work ﬂow.
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Figure 6. Pediatric transplant telemedicine work ﬂow. Abbreviations: AKI, acute kidney injury; BK/CMV/EBV PCR, polyomavirus BK/
cytomegalovirus/Epstein-Barr virus polymerase chain reaction; CBC, complete blood cell count; COVID-19, coronavirus disease
2019; DSA, donor-speciﬁc antibodies; IS, immunosuppression; labs, laboratory tests; max, maximum; PO, orally; UA, urine albumin;
Ur, urinary.

1 to 2 months before the transfer date to prepare both family
and patients for the shift in responsibilities. To provide
similar levels of education, regular telemedicine visits are
essential to check on the progress of the family and patient.
Regularly scheduled visits allow for physicians to check
patients’ understanding of their kidney’s health and the
processes required to keep it healthy. Independent questionnaires that assess their understanding of their health care
rights, how to make follow-up appointments, and manage
comorbid conditions can be delivered online. Similarly,
other members of the health care team such as social workers
and dieticians can be reached through telemedicine visits to
provide information about insurance, support systems, and
proper nutrition.
Home Hemodialysis
Home hemodialysis has been shown to have multiple
benefits in regard to psychological, clinical, and
biochemical parameters (Fig 8). It is imperative to
transition patients to home units to limit their exposure to SARS-CoV-2 in the hospital. During the initial
chronic kidney disease diagnosis, patients should be
educated on the risks of each stage and what to do if
the need for dialysis arises. If the patient is at stage 4,
they should be educated on the feasibility of home
hemodialysis. If the patient can undergo the treatment
at home, a home assessment and installation of the
proper infrastructure should be done. Patients should
422

be educated and given the means to perform home
blood pressure monitoring as well. At the conclusion
of infrastructure installation, patients should be monitored remotely for cases of infection, need for transplant/transfer, or death.
Remote Peritoneal Dialysis
For patients who receive peritoneal dialysis, COVID-19 has
created a roadblock to routine office visits. Furthermore,
nephrologists are unable to see each patient’s dialysis cycle
information without such visits. A solution to this has been
Sharesource, an online platform that allows for medical
professionals to remotely monitor each patient’s dialysis
information.14 Sharesource has been widely implemented
by nephrologists at Mt. Sinai, where 80% of patients are
now being monitored remotely with this technology. This
can provide nephrologists with access to dialysis information, and with virtual office visits providing an opportunity to meet with patients, the ability for nephrologists
to remotely monitor and treat patients receiving peritoneal
dialysis has now become a reality.

LIMITATIONS AND FUTURE CONSIDERATIONS
There are a few limitations that can serve as avenues for
future research. In the survey released to both patients and
providers, data on demographics and relative access to the
internet were not gathered. This information could be used
Kidney Med Vol 3 | Iss 3 | May–June 2021
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Transition from Pediatric to Adult Practice Workﬂow
Identify, select, and include the appropriate Adult Nephrology Hemodialysis or Home Hemodialysis
Nephrology Services

1

Problem: Differences in expectations, resources and support provided by pediatric and adult
nephrology units along with often inadequate preparation of the young person by
pediatric units, can compound this problem

2

• Accurate and relevant information ﬂow between pediatric and adult health services, facilitated by
effective communications channels, is a commonly reported factor contributing to successful transition
• An Action Plan Card Tool should be created to guide adult provider to manage, and facilitate the
transition process, ensuring minimal disruption to health service provision
• The action plan should be developed in accordance with continuous quality improvement (CQI)
processes and include measurements of the effect of implementation clinical practice guidelines

Action Plan Tool

• Transfer of Care Cover letter
• Authorization for release of medical information
• Checklist of Records for Transfer of Care
• Plan of care, including transition goals and pending actions
• Emergency care plan
• Guardianship or health proxy documents, if needed
A) Step 1
a. Develop a self-management ability so that patients can establish an appropriate daily routine,
have knowledge of their medical history, and understand their medications and side effects
B) Step 2
a. Facilitate discussions that help the patient explore factors interfering with adherence (such as
forgetfulness and poor social planning), identify solutions, and create habits that will foster
adherence
b. Establishing basic survival skills for an adult clinic so that transitioning adolescents are able
to discuss their own medical condition and present problems to the new providers, schedule
appointments, and ﬁll or reﬁll prescriptions

Action Transition
• Ongoing evaluation of assessment and readiness
• Engagement of Combined Pediatric and Adult Transition Team in partnership with
young person and family/caregivers
• Combined clinic visit with pediatric and adult nephrologist in the transition clinic to assess
the need, deﬁne goals, responsibility, and care plan
• Successful transfer to adult services

Integration
•
•
•
•

Completed transfer and integration into adult services
Combined care teleconference at 6 months including all pediatric and adult services
After three consecutive visits by adult nephrologist, quality outcomes evaluation will be performed
Ongoing evaluation at 1, 2, 3 and 5 years

Figure 7. Transition from pediatric to adult care work ﬂow

to better tailor work flows to various communities and
minimize health disparities. To date, there are no preliminary data, besides with peritoneal dialysis, on the efficacy of these work flows in practice. Future research and
analysis of their implementation will allow for adjustments
to be made to improve their quality.
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CONCLUSION
To deliver the most effective treatments for patients,
standardized telemedicine work flows are imperative. With
the COVID-19 pandemic continuing for an indeterminate
time, coupled with the impending flu season, there is an
ever-increasing need for telemedicine services. We believe
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Figure 8. Home hemodialysis (HD) protocol. Abbreviations: BP, blood pressure; CKD, chronic kidney disease; COVID-19, coronavirus disease 2019; PD, peritoneal dialysis; PTH, parathyroid hormone.

that adaptation of these work flows can provide the
foundation toward delivering standardized care to patients
across the nation.
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